Please enable JavaScript to continue using this application.

Compare $KLRA vs $XNCR | Chartloom

Compare

$KLRA vs $XNCR

Kailera Therapeutics Inc · Xencor Inc

KLRA

Kailera Therapeutics Inc

XNCR

Xencor Inc

Compare $KLRA vs $XNCR

Comparing Kailera Therapeutics Inc and Xencor Inc

KLRAKailera Therapeutics Inc

XNCRXencor Inc

KLRAKailera Therapeutics Inc

Market cap

$1.50B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-55.3%

52W performance

-55.3%

FCF yield

0.0%

XNCRXencor Inc

Market cap

$1.83B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.26x

Rev growth (TTM)

-33.2%

YTD performance

65.1%

52W performance

98.6%

FCF yield

-11.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KLRA

XNCR

Detailed metrics comparison

KLRA

Kailera Therapeutics Inc

XNCR

Xencor Inc

Market Cap

KLRA$1.50B

XNCR$1.83B

Enterprise Value

KLRA$1.37B

XNCR$1.89B

Price

KLRA$11.61

XNCR$24.63

P/E Ratio

KLRAN/A

XNCRN/A

P/S Ratio

KLRA0.00x

XNCR17.40x

EV/Sales

KLRA0.00x

XNCR17.97x

EV/EBITDA

KLRA0.00x

XNCR31.73x

P/B Ratio

KLRA1.20x

XNCR3.71x

P/FCF Ratio

KLRAN/A

XNCRN/A

EV/FCF

KLRA0.00x

XNCR-9.06x

PEG Ratio

KLRAN/A

XNCRN/A

Forward P/E (NTM)

KLRAN/A

XNCRN/A

Forward P/S (NTM)

KLRAN/A

XNCR14.26x

Revenue (TTM)

KLRA$0

XNCR$105M

Revenue Growth (YoY)

KLRAN/A

XNCR-33.2%

Forward Rev Growth

KLRA275.8%

XNCR7.4%

Gross Margin (TTM)

KLRA0.0%

XNCR0.0%

Operating Margin (TTM)

KLRA0.0%

XNCR0.0%

EBITDA Margin (TTM)

KLRA0.0%

XNCR-188.5%

Net Margin (TTM)

KLRA0.0%

XNCR-155.6%

FCF Margin (TTM)

KLRAN/A

XNCR-198.4%

Net Income (TTM)

KLRA$-190M

XNCR$-163M

FCF (TTM)

KLRA$0

XNCR$-208M

EPS (TTM)

KLRA-$1.86

XNCR-$2.15

ROE (TTM)

KLRA0.0%

XNCR-2866.0%

ROA (TTM)

KLRA0.0%

XNCR-2038.0%

ROIC (TTM)

KLRA0.0%

XNCR-2379.0%

Cash

KLRA$130M

XNCR$45M

Debt

KLRA$0

XNCR$105M

Net Cash/Debt

KLRA$130M

XNCR$-60M

Current Ratio (TTM)

KLRA11.11x

XNCR6.39x

Quick Ratio (TTM)

KLRA11.04x

XNCR6.09x

Debt/Equity (TTM)

KLRA0.00x

XNCR0.21x

Debt/Assets (TTM)

KLRA0.0%

XNCR0.0%

Interest Coverage (TTM)

KLRAN/A

XNCRN/A

Net Debt/EBITDA (TTM)

KLRA0.00x

XNCR0.00x

Beta

KLRA2.22

XNCR0.81

52W Performance

KLRA-55.3%

XNCR98.6%

YTD Performance

KLRA-55.3%

XNCR65.1%

% from 52W High

KLRA-58.9%

XNCR-19.5%

% from 52W Low

KLRA19.0%

XNCR137.4%

Asset Turnover (TTM)

KLRA0.00x

XNCR0.13x

FCF Yield (TTM)

KLRA0.0%

XNCR-11.4%

Earnings Yield (TTM)

KLRA-12.6%

XNCR-8.9%

Dividend Yield (TTM)

KLRAN/A

XNCRN/A

Rule of 40

KLRA0.0

XNCR-231.6

EV/GP/RG

KLRAN/A

XNCRN/A

Ticker research

View KLRA research View XNCR research

Metric	KLRA Kailera Therapeutics Inc	XNCR Xencor Inc
Market & Valuation
Market Cap	$1.50B	$1.83B
Enterprise Value	$1.37B	$1.89B
Price	$11.61	$24.63
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	17.40x
EV/Sales	0.00x	17.97x
EV/EBITDA	0.00x	31.73x
P/B Ratio	1.20x	3.71x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-9.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	14.26x
Revenue & Growth
Revenue (TTM)	$0	$105M
Revenue Growth (YoY)	N/A	-33.2%
Forward Rev Growth	275.8%	7.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-188.5%
Net Margin (TTM)	0.0%	-155.6%
FCF Margin (TTM)	N/A	-198.4%
Net Income (TTM)	$-190M	$-163M
FCF (TTM)	$0	$-208M
EPS (TTM)	-$1.86	-$2.15
ROE (TTM)	0.0%	-2866.0%
ROA (TTM)	0.0%	-2038.0%
ROIC (TTM)	0.0%	-2379.0%
Financial Health
Cash	$130M	$45M
Debt	$0	$105M
Net Cash/Debt	$130M	$-60M
Current Ratio (TTM)	11.11x	6.39x
Quick Ratio (TTM)	11.04x	6.09x
Debt/Equity (TTM)	0.00x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.22	0.81
52W Performance	-55.3%	98.6%
YTD Performance	-55.3%	65.1%
% from 52W High	-58.9%	-19.5%
% from 52W Low	19.0%	137.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.13x
FCF Yield (TTM)	0.0%	-11.4%
Earnings Yield (TTM)	-12.6%	-8.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-231.6
EV/GP/RG	N/A	N/A
Ticker research	View KLRA research	View XNCR research

Valuation

P/S Ratio

KLRA

0.00x

XNCR

17.40x

EV/FCF

XNCR

-9.06x

KLRA

0.00x

Growth & revenue

Revenue Growth TTM

XNCR

-33.2%

Forward Revenue Growth

KLRA

275.8%

XNCR

7.4%

Profitability & performance

Gross Margin

KLRA

0.0%

XNCR

0.0%

ROE

KLRA

0.0%

XNCR

-2866.0%

FCF Yield %

KLRA

0.0%

XNCR

-11.4%

52-Week Performance

XNCR

98.6%

KLRA

-55.3%

Detailed metrics comparison

KLRA

Kailera Therapeutics Inc

XNCR

Xencor Inc

Market Cap

KLRA$1.50B

XNCR$1.83B

Enterprise Value

KLRA$1.37B

XNCR$1.89B

Price

KLRA$11.61

XNCR$24.63

P/E Ratio

KLRAN/A

XNCRN/A

P/S Ratio

KLRA0.00x

XNCR17.40x

EV/Sales

KLRA0.00x

XNCR17.97x

EV/EBITDA

KLRA0.00x

XNCR31.73x

P/B Ratio

KLRA1.20x

XNCR3.71x

P/FCF Ratio

KLRAN/A

XNCRN/A

EV/FCF

KLRA0.00x

XNCR-9.06x

PEG Ratio

KLRAN/A

XNCRN/A

Forward P/E (NTM)

KLRAN/A

XNCRN/A

Forward P/S (NTM)

KLRAN/A

XNCR14.26x

Revenue (TTM)

KLRA$0

XNCR$105M

Revenue Growth (YoY)

KLRAN/A

XNCR-33.2%

Forward Rev Growth

KLRA275.8%

XNCR7.4%

Gross Margin (TTM)

KLRA0.0%

XNCR0.0%

Operating Margin (TTM)

KLRA0.0%

XNCR0.0%

EBITDA Margin (TTM)

KLRA0.0%

XNCR-188.5%

Net Margin (TTM)

KLRA0.0%

XNCR-155.6%

FCF Margin (TTM)

KLRAN/A

XNCR-198.4%

Net Income (TTM)

KLRA$-190M

XNCR$-163M

FCF (TTM)

KLRA$0

XNCR$-208M

EPS (TTM)

KLRA-$1.86

XNCR-$2.15

ROE (TTM)

KLRA0.0%

XNCR-2866.0%

ROA (TTM)

KLRA0.0%

XNCR-2038.0%

ROIC (TTM)

KLRA0.0%

XNCR-2379.0%

Cash

KLRA$130M

XNCR$45M

Debt

KLRA$0

XNCR$105M

Net Cash/Debt

KLRA$130M

XNCR$-60M

Current Ratio (TTM)

KLRA11.11x

XNCR6.39x

Quick Ratio (TTM)

KLRA11.04x

XNCR6.09x

Debt/Equity (TTM)

KLRA0.00x

XNCR0.21x

Debt/Assets (TTM)

KLRA0.0%

XNCR0.0%

Interest Coverage (TTM)

KLRAN/A

XNCRN/A

Net Debt/EBITDA (TTM)

KLRA0.00x

XNCR0.00x

Beta

KLRA2.22

XNCR0.81

52W Performance

KLRA-55.3%

XNCR98.6%

YTD Performance

KLRA-55.3%

XNCR65.1%

% from 52W High

KLRA-58.9%

XNCR-19.5%

% from 52W Low

KLRA19.0%

XNCR137.4%

Asset Turnover (TTM)

KLRA0.00x

XNCR0.13x

FCF Yield (TTM)

KLRA0.0%

XNCR-11.4%

Earnings Yield (TTM)

KLRA-12.6%

XNCR-8.9%

Dividend Yield (TTM)

KLRAN/A

XNCRN/A

Rule of 40

KLRA0.0

XNCR-231.6

EV/GP/RG

KLRAN/A

XNCRN/A

Ticker research

View KLRA research View XNCR research

Metric	KLRA Kailera Therapeutics Inc	XNCR Xencor Inc
Market & Valuation
Market Cap	$1.50B	$1.83B
Enterprise Value	$1.37B	$1.89B
Price	$11.61	$24.63
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	17.40x
EV/Sales	0.00x	17.97x
EV/EBITDA	0.00x	31.73x
P/B Ratio	1.20x	3.71x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-9.06x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	14.26x
Revenue & Growth
Revenue (TTM)	$0	$105M
Revenue Growth (YoY)	N/A	-33.2%
Forward Rev Growth	275.8%	7.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-188.5%
Net Margin (TTM)	0.0%	-155.6%
FCF Margin (TTM)	N/A	-198.4%
Net Income (TTM)	$-190M	$-163M
FCF (TTM)	$0	$-208M
EPS (TTM)	-$1.86	-$2.15
ROE (TTM)	0.0%	-2866.0%
ROA (TTM)	0.0%	-2038.0%
ROIC (TTM)	0.0%	-2379.0%
Financial Health
Cash	$130M	$45M
Debt	$0	$105M
Net Cash/Debt	$130M	$-60M
Current Ratio (TTM)	11.11x	6.39x
Quick Ratio (TTM)	11.04x	6.09x
Debt/Equity (TTM)	0.00x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.22	0.81
52W Performance	-55.3%	98.6%
YTD Performance	-55.3%	65.1%
% from 52W High	-58.9%	-19.5%
% from 52W Low	19.0%	137.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.13x
FCF Yield (TTM)	0.0%	-11.4%
Earnings Yield (TTM)	-12.6%	-8.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-231.6
EV/GP/RG	N/A	N/A
Ticker research	View KLRA research	View XNCR research